Aeolus Pharmaceuticl (AOLS)

OTC Markets
0.0001
0.0000(0.00%)
  • वॉल्यूम:
    0
  • बोली/पुछे:
    0.0000/0.0000
  • दिन की रेंज:
    0.0001 - 0.0001

AOLS समीक्षा

पिछला बंद
0.0001
दिन की रेंज
0.0001-0.0001
आय
-
खुला
0.0001
52 सप्ताह रेंज
0.0001-0.008
ईपीएस
-0.03
वॉल्यूम
0
मार्केट कैप
15.21K
लाभांश (यील्ड)
N/A
(N/A)
औसत वॉल्यूम (3एम)
11,242
पी/ई अनुपात
-
बीटा
1.71
1- वर्ष बदलाव
-98.53%
बकाया शेयर
152,085,825
अगली कमाई तिथि
14 अग॰ 2022
Aeolus Pharmaceuticl पर आपकी भावना क्या है?
या
समुदाय परिणामों को देखने के लिए वोट करें!

Aeolus Pharmaceuticl कंपनी प्रोफाइल

Aeolus Pharmaceuticl कंपनी प्रोफाइल

Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and oncology. Its lead compound includes AEOL 10150 that has completed two Phase I clinical trials, which is developed against the pulmonary sub-syndrome of acute radiation syndrome; and for use as a medical countermeasure for exposure to chemical vesicants and nerve agents. The company is also developing AEOL 11114B, AEOL 11203, and AEOL 11207 for the treatment of Parkinson’s disease, as well as AEOL 20415 for treating infectious diseases. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California.

और पढ़ें

तकनीकी सारांश

प्रकार
5 मिनट
15 मिनट
प्रति घंटा
दैनिक
मासिक
मूविंग एवरेजबेचनाखरीदेंमजबूत विक्रयमजबूत विक्रय
तकनीकी संकेतकखरीदेंखरीदेंमजबूत विक्रयमजबूत विक्रय
सारांशतटस्थखरीदेंमजबूत विक्रयमजबूत विक्रय